{
    "2019-08-20": [
        [
            {
                "time": "",
                "original_text": "社保基金二季度青睐生物医药，调仓布局路径浮出水面（附名单）",
                "features": {
                    "keywords": [
                        "社保基金",
                        "生物医药",
                        "调仓",
                        "二季度"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "新进医保目录的独家品种",
                "features": {
                    "keywords": [
                        "医保目录",
                        "独家品种"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【药乾坤】这笔操作666，999皮炎平引领新一轮跨界热潮",
                "features": {
                    "keywords": [
                        "药乾坤",
                        "皮炎平",
                        "跨界"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【民生医药|中报总结】医药板块2019中报总结：增长的韧劲足，逐步加仓二线龙头",
                "features": {
                    "keywords": [
                        "民生医药",
                        "中报总结",
                        "医药板块",
                        "二线龙头"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "数据洞察：2019医保目录调整，影响6000+药品文号",
                "features": {
                    "keywords": [
                        "数据洞察",
                        "医保目录",
                        "调整",
                        "药品文号"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}